Cardiovascular diseases (CVDs) are the major causes of death in the western world. The incidence of cardiovascular disease as well as the rate of cardiovascular mortality and morbidity increase exponentially in the elderly population, suggesting that age per se is a major risk factor of CVDs. The physiologic changes of human cardiac aging mainly include left ventricular hypertrophy, diastolic dysfunction, valvular degeneration, increased cardiac fibrosis, increased prevalence of atrial fibrillation, and decreased maximal exercise capacity. Many of these changes are closely recapitulated in animal models commonly used in an aging study, including rodents, flies, and monkeys. The application of genetically modified aged mice has provided direct evidence of several critical molecular mechanisms involved in cardiac aging, such as mitochondrial oxidative stress, insulin/insulin-like growth factor/PI3K pathway, adrenergic and renin angiotensin II signaling, and nutrient signaling pathways. This article also reviews the central role of mitochondrial oxidative stress in CVDs and the plausible mechanisms underlying the progression toward heart failure in the susceptible aging hearts. Finally, the understanding of the molecular mechanisms of cardiac aging may support the potential clinical application of several “anti-aging” strategies that treat CVDs and improve healthy cardiac aging.
AbadirPM, FosterDB, CrowM, CookeCA, RuckerJJ, JainA, SmithBJ, BurksTN, CohnRD, FedarkoNS, CareyRM, O'RourkeB, WalstonJD. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A, 108:14849–14854. 2011.
2.
AdlamVJ, HarrisonJC, PorteousCM, JamesAM, SmithRA, MurphyMP, SammutIA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. Faseb J, 19:1088–1095. 2005.
3.
AgoT, KurodaJ, PainJ, FuC, LiH, SadoshimaJ. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res, 106:1253–1264. 2010.
4.
AhmedHM, BlahaMJ, NasirK, RiveraJJ, BlumenthalRS. Effects of physical activity on cardiovascular disease. Am J Cardiol, 109:288–295. 2012.
5.
AhmetI, TaeHJ, de CaboR, LakattaEG, TalanMI. Effects of calorie restriction on cardioprotection and cardiovascular health. J Mol Cell Cardiol, 51:263–271. 2011.
6.
AkazawaH, KomazakiS, ShimomuraH, TerasakiF, ZouY, TakanoH, NagaiT, KomuroI. Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure. J Biol Chem, 279:41095–41103. 2004.
7.
AkinsCW, DaggettWM, VlahakesGJ, HilgenbergAD, TorchianaDF, MadsenJC, BuckleyMJ. Cardiac operations in patients 80 years old and older. Ann Thorac Surg, 64:606–614discussion 614–6151997.
8.
AlcendorRR, GaoS, ZhaiP, ZablockiD, HolleE, YuX, TianB, WagnerT, VatnerSF, SadoshimaJ. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res, 100:1512–1521. 2007.
9.
AndersonEJ, LustigME, BoyleKE, WoodliefTL, KaneDA, LinCT, PriceJW3rd, KangL, RabinovitchPS, SzetoHH, HoumardJA, CortrightRN, WassermanDH, NeuferPD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest, 119:573–581. 2009.
10.
AndersonRM, BittermanKJ, WoodJG, MedvedikO, SinclairDA. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature, 423:181–185. 2003.
11.
AnderssonDC, FauconnierJ, YamadaT, LacampagneA, ZhangSJ, KatzA, WesterbladH. Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes. J Physiol, 589:1791–1801. 2011.
12.
AntonenkoYN, AvetisyanAV, BakeevaLE, ChernyakBV, ChertkovVA, DomninaLV, IvanovaOY, IzyumovDS, KhailovaLS, KlishinSS, KorshunovaGA, LyamzaevKG, MuntyanMS, NepryakhinaOK, PashkovskayaAA, PletjushkinaOY, PustovidkoAV, RoginskyVA, RokitskayaTI, RuugeEK, SaprunovaVB, SeverinaII, SimonyanRA, SkulachevIV, SkulachevMV, SumbatyanNV, SviryaevaIV, TashlitskyVN, VassilievJM, VyssokikhMY, YaguzhinskyLS, ZamyatninAAJr., SkulachevVP. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc), 73:1273–1287. 2008.
13.
AnversaP, PuntilloE, NikitinP, OlivettiG, CapassoJM, SonnenblickEH. Effects of age on mechanical and structural properties of myocardium of Fischer 344 rats. Am J Physiol, 256:H1440–H1449. 1989.
14.
AnyukhovskyEP, SosunovEA, ChandraP, RosenTS, BoydenPA, DaniloPJr., RosenMR. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc Res, 66:353–363. 2005.
15.
ApfeldJ, KenyonC. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell, 95:199–210. 1998.
16.
Arbab-ZadehA, DijkE, PrasadA, FuQ, TorresP, ZhangR, ThomasJD, PalmerD, LevineBD. Effect of aging and physical activity on left ventricular compliance. Circulation, 110:1799–1805. 2004.
17.
AronowWS, AhnC, ShiraniJ, KronzonI. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol, 83:599–600A81999.
18.
BaccarelliA, WrightR, BollatiV, LitonjuaA, ZanobettiA, TarantiniL, SparrowD, VokonasP, SchwartzJ. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology, 21:819–828. 2010.
19.
BakeevaLE, BarskovIV, EgorovMV, IsaevNK, KapelkoVI, KazachenkoAV, KirpatovskyVI, KozlovskySV, LakomkinVL, LevinaSB, PisarenkoOI, PlotnikovEY, SaprunovaVB, SerebryakovaLI, SkulachevMV, StelmashookEV, StudnevaIM, TskitishviliOV, VasilyevaAK, VictorovIV, ZorovDB, SkulachevVP. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)Biochemistry (Mosc), 73:1288–1299. 2008.
20.
BargerJL, KayoT, VannJM, AriasEB, WangJ, HackerTA, WangY, RaederstorffD, MorrowJD, LeeuwenburghC, AllisonDB, SaupeKW, CarteeGD, WeindruchR, ProllaTA. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One, 3:e2264. 2008.
21.
BassTM, WeinkoveD, HouthoofdK, GemsD, PartridgeL. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev, 128:546–552. 2007.
22.
BassoN, CiniR, PietrelliA, FerderL, TerragnoNA, InserraF. Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol, 293:H1351–H1358. 2007.
23.
BaurJA, PearsonKJ, PriceNL, JamiesonHA, LerinC, KalraA, PrabhuVV, AllardJS, Lopez-LluchG, LewisK, PistellPJ, PoosalaS, BeckerKG, BossO, GwinnD, WangM, RamaswamyS, FishbeinKW, SpencerRG, LakattaEG, Le CouteurD, ShawRJ, NavasP, PuigserverP, IngramDK, de CaboR, SinclairDA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444:337–342. 2006.
24.
BaurJA, SinclairDA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov, 5:493–506. 2006.
25.
BeckerLB, vanden HoekTL, ShaoZH, LiCQ, SchumackerPT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol, 277:H2240–H2246. 1999.
26.
BeerM, SeyfarthT, SandstedeJ, LandschutzW, LipkeC, KostlerH, von KienlinM, HarreK, HahnD, NeubauerS. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol, 40:1267–1274. 2002.
27.
BellizziD, RoseG, CavalcanteP, CovelloG, DatoS, De RangoF, GrecoV, MaggioliniM, FeracoE, MariV, FranceschiC, PassarinoG, De BenedictisG. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics, 85:258–263. 2005.
28.
BeltramiAP, BarlucchiL, TorellaD, BakerM, LimanaF, ChimentiS, KasaharaH, RotaM, MussoE, UrbanekK, LeriA, KajsturaJ, Nadal-GinardB, AnversaP. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114:763–776. 2003.
29.
BenigniA, CornaD, ZojaC, SonzogniA, LatiniR, SalioM, ContiS, RottoliD, LongarettiL, CassisP, MorigiM, CoffmanTM, RemuzziG. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest, 119:524–530. 2009.
30.
BeregiE, RegiusO. Comparative morphological study of age related mitochondrial changes of the lymphocytes and skeletal muscle cells. Acta Morphol Hung, 35:219–224. 1987.
BersDM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda), 21:380–387. 2006.
34.
BjelakovicG, NikolovaD, GluudLL, SimonettiRG, GluudC. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA, 297:842–857. 2007.
BoluytMO, ConversoK, HwangHS, MikkorA, RussellMW. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol, 96:822–828. 2004.
BoyleAJ, ShihH, HwangJ, YeJ, LeeB, ZhangY, KwonD, JunK, ZhengD, SieversR, AngeliF, YeghiazariansY, LeeR. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol, 46:549–559. 2011.
39.
BraidyN, GuilleminGJ, MansourH, Chan-LingT, PoljakA, GrantR. Age related changes in NAD+metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One, 6:e19194. 2011.
40.
BroglioF, FubiniA, MorelloM, ArvatE, AimarettiG, GianottiL, BoghenMF, DeghenghiR, MangiardiL, GhigoE. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol (Oxf), 50:417–430. 1999.
41.
BrownVA, PatelKR, ViskadurakiM, CrowellJA, PerloffM, BoothTD, VasilininG, SenA, SchinasAM, PiccirilliG, BrownK, StewardWP, GescherAJ, BrennerDE. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res, 70:9003–9011. 2010.
42.
BrunkUT, TermanA. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem, 269:1996–2002. 2002.
43.
BursiF, WestonSA, RedfieldMM, JacobsenSJ, PakhomovS, NkomoVT, MeverdenRA, RogerVL. Systolic and diastolic heart failure in the community. Jama, 296:2209–2216. 2006.
44.
CadenasS, AragonesJ, LandazuriMO. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc Res, 88:219–228. 2010.
45.
CaiZ, ZhongH, Bosch-MarceM, Fox-TalbotK, WangL, WeiC, TrushMA, SemenzaGL. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res, 77:463–470. 2008.
ChanDC. Mitochondria: dynamic organelles in disease, aging, and development. Cell, 125:1241–1252. 2006.
48.
ChanNC, SalazarAM, PhamAH, SweredoskiMJ, KolawaNJ, GrahamRL, HessS, ChanDC. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet, 20:1726–1737. 2011.
49.
ChandelNS, MaltepeE, GoldwasserE, MathieuCE, SimonMC, SchumackerPT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A, 95:11715–11720. 1998.
50.
ChenH, ChanDC. Physiological functions of mitochondrial fusion. Ann N Y Acad Sci, 1201:21–25. 2010.
51.
ChenH, VermulstM, WangYE, ChomynA, ProllaTA, McCafferyJM, ChanDC. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell, 141:280–289. 2010.
52.
ChimentiC, KajsturaJ, TorellaD, UrbanekK, HeleniakH, ColussiC, Di MeglioF, Nadal-GinardB, FrustaciA, LeriA, MaseriA, AnversaP. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res, 93:604–613. 2003.
53.
ChiribauCB, ChengL, CucoranuIC, YuYS, ClempusRE, SorescuD. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J Biol Chem, 283:8211–8217. 2008.
ChomynA, MeolaG, BresolinN, LaiST, ScarlatoG, AttardiG. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol, 11:2236–2244. 1991.
57.
ChouTC, YenMH, LiCY, DingYA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension, 31:643–648. 1998.
58.
ChudykA, PetrellaRJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care, 34:1228–1237. 2011.
ColomB, OliverJ, RocaP, Garcia-PalmerFJ. Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage. Cardiovasc Res, 74:456–465. 2007.
61.
CorpasE, HarmanSM, BlackmanMR. Human growth hormone and human aging. Endocr Rev, 14:20–39. 1993.
62.
Corral-DebrinskiM, StepienG, ShoffnerJM, LottMT, KanterK, WallaceDC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. Jama, 266:1812–1816. 1991.
63.
CorreiaLC, LakattaEG, O'ConnorFC, BeckerLC, ClulowJ, TownsendS, GerstenblithG, FlegJL. Attenuated cardiovascular reserve during prolonged submaximal cycle exercise in healthy older subjects. J Am Coll Cardiol, 40:1290–1297. 2002.
64.
CruzenC, ColmanRJ. Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin Geriatr Med, 25:733–743ix–x2009.
65.
CurtisNJ, RingoJM, DowseHB. Morphology of the pupal heart, adult heart, and associated tissues in the fruit fly, Drosophila melanogaster. J Morphol, 240:225–235. 1999.
DaiDF, ChenT, WanagatJ, LaflammeM, MarcinekDJ, EmondMJ, NgoCP, ProllaTA, RabinovitchPS. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell, 9:536–544. 2010.
68.
DaiDF, HwangJJ, ChenCL, ChiangFT, LinJL, HsuKL, TsengCD, TsengYZ. Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc, 109:716–724. 2010.
DormanJB, AlbinderB, ShroyerT, KenyonC. The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics, 141:1399–1406. 1995.
78.
DoughanAK, DikalovSI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal, 9:1825–1836. 2007.
DucharmeA, FrantzS, AikawaM, RabkinE, LindseyM, RohdeLE, SchoenFJ, KellyRA, WerbZ, LibbyP, LeeRT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest, 106:55–62. 2000.
81.
EckleT, KohlerD, LehmannR, El KasmiK, EltzschigHK. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation, 118:166–175. 2008.
82.
EllisonKE, GandhiG. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease. Drugs, 65:787–797. 2005.
83.
EvansGB, FurneauxRH, GainsfordGJ, HansonJC, KicskaGA, SauveAA, SchrammVL, TylerPC. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases. J Med Chem, 46:155–160. 2003.
84.
FagardRH. Effects of exercise, diet and their combination on blood pressure. J Hum Hypertens, 19,Suppl 3:S20–S24. 2005.
85.
FaggianoP, Antonini-CanterinF, ErlicherA, RomeoC, CervesatoE, PavanD, PiazzaR, HuangG, NicolosiGL. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol, 91:99–101. 2003.
86.
FinocchiettoPV, FrancoMC, HolodS, GonzalezAS, ConversoDP, Antico ArciuchVG, SerraMP, PoderosoJJ, CarrerasMC. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood), 234:1020–1028. 2009.
87.
FlegJL, O'ConnorF, GerstenblithG, BeckerLC, ClulowJ, SchulmanSP, LakattaEG. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol, 78:890–900. 1995.
88.
FloreaniM, NapoliE, QuintieriL, PalatiniP. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci, 72:2741–2750. 2003.
89.
Flores-MateoG, Carrillo-SantisteveP, ElosuaR, GuallarE, MarrugatJ, BleysJ, CovasMI. Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies. Am J Epidemiol, 170:135–147. 2009.
90.
FooRS, ManiK, KitsisRN. Death begets failure in the heart. J Clin Invest, 115:565–571. 2005.
91.
FormanDE, CittadiniA, AzharG, DouglasPS, WeiJY. Cardiac morphology and function in senescent rats: gender-related differences. J Am Coll Cardiol, 30:1872–1877. 1997.
92.
FowlerCG, ChiassonKB, LeslieTH, ThomasD, BeasleyTM, KemnitzJW, WeindruchR. Auditory function in rhesus monkeys: effects of aging and caloric restriction in the Wisconsin monkeys five years later. Hear Res, 261:75–81. 2010.
93.
FrankelEN, WaterhouseAL, KinsellaJE. Inhibition of human LDL oxidation by resveratrol. Lancet, 341:1103–1104. 1993.
94.
FreemanRV, OttoCM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation, 111:3316–3326. 2005.
95.
FrishmanWH. Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology. Am J Med, 121:933–934. 2008.
96.
FujimotoN, PrasadA, HastingsJL, Arbab-ZadehA, BhellaPS, ShibataS, PalmerD, LevineBD. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation, 122:1797–1805. 2010.
97.
FulkersonPK, BeaverBM, AuseonJC, GraberHL. Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. Am J Med, 66:967–977. 1979.
98.
GaneEJ, WeilertF, OrrDW, KeoghGF, GibsonM, LockhartMM, FramptonCM, TaylorKM, SmithRA, MurphyMP. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int, 30:1019–1026. 2010.
99.
GaoL, WangW, LiuD, ZuckerIH. Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation, 115:3095–3102. 2007.
GardinJM, LauerMS. Left ventricular hypertrophy: the next treatable, silent killer?Jama, 292:2396–2398. 2004.
102.
GatesPE, TanakaH, GravesJ, SealsDR. Left ventricular structure and diastolic function with human ageing. Relation to habitual exercise and arterial stiffness. Eur Heart J, 24:2213–2220. 2003.
103.
GiannakouME, GossM, JungerMA, HafenE, LeeversSJ, PartridgeL. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science, 305:361. 2004.
104.
GluckmanPD, HansonMA, BuklijasT, LowFM, BeedleAS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol, 5:401–408. 2009.
105.
GoffartS, von Kleist-RetzowJ-C, WiesnerRJ. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovascular Research, 64:198–207. 2004.
GravinaS, VijgJ. Epigenetic factors in aging and longevity. Pflugers Arch, 459:247–258. 2010.
111.
GrobanL, PailesNA, BennettCD, CarterCS, ChappellMC, KitzmanDW, SonntagWE. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci, 61:28–35. 2006.
112.
GuglielminiC. Cardiovascular diseases in the ageing dog: diagnostic and therapeutic problems. Vet Res Commun, 27,Suppl 1:555–560. 2003.
113.
GuzyRD, HoyosB, RobinE, ChenH, LiuL, MansfieldKD, SimonMC, HammerlingU, SchumackerPT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab, 1:401–408. 2005.
114.
HachamovitchR, WickerP, CapassoJM, AnversaP. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol, 256:H66–H73. 1989.
115.
HafnerAV, DaiJ, GomesAP, XiaoCY, PalmeiraCM, RosenzweigA, SinclairDA. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY), 2:914–923. 2010.
HamanakaRB, ChandelNS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci, 35:505–513. 2010.
118.
HamlinRL. Animal models of ventricular arrhythmias. Pharmacol Ther, 113:276–295. 2007.
119.
HamlinRL, SmithCR. Anatomical and physiologic basis for interpretation of the electrocardiogram. Am J Vet Res, 21:701–708. 1960.
120.
HariharanN, MaejimaY, NakaeJ, PaikJ, DepinhoRA, SadoshimaJ. Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes. Circ Res, 107:1470–1482. 2010.
121.
HarmanD. Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
122.
HarmanD. The biologic clock: the mitochondria?J Am Geriatr Soc, 20:145–147. 1972.
123.
HeinekeJ, Auger-MessierM, XuJ, OkaT, SargentMA, YorkA, KlevitskyR, VaikunthS, DuncanSA, AronowBJ, RobbinsJ, CrombleholmeTM, MolkentinJD. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest, 117:3198–3210. 2007.
124.
HeppleRT, BakerDJ, McConkeyM, MurynkaT, NorrisR. Caloric restriction protects mitochondrial function with aging in skeletal and cardiac muscles. Rejuvenation Res, 9:219–222. 2006.
125.
HerbertKE, MistryY, HastingsR, PoolmanT, NiklasonL, WilliamsB. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res, 102:201–208. 2008.
126.
HesselinkRP, SchaartG, WagenmakersAJ, DrostMR, van der VusseGJ. Age-related morphological changes in skeletal muscle cells of acid alpha-glucosidase knockout mice. Muscle Nerve, 33:505–513. 2006.
127.
HobaiIA, O'RourkeB. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation, 103:1577–1584. 2001.
HoshijimaM, IkedaY, IwanagaY, MinamisawaS, DateMO, GuY, IwatateM, LiM, WangL, WilsonJM, WangY, RossJJr., ChienKR. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med, 8:864–871. 2002.
130.
HosoiH, DillingMB, ShikataT, LiuLN, ShuL, AshmunRA, GermainGS, AbrahamRT, HoughtonPJ. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res, 59:886–894. 1999.
HuangTT, CarlsonEJ, GillespieAM, ShiY, EpsteinCJ. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci, 55:B5–B9. 2000.
133.
InserraF, BassoN, FerderM, UserpaterM, StellaI, PagliaN, InserraP, TenembaumD, FerderL. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system. Ther Adv Cardiovasc Dis, 3:341–346. 2009.
134.
IsoyamaS, Nitta-KomatsubaraY. Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Fail Rev, 7:63–69. 2002.
135.
IzumiyaY, ShiojimaI, SatoK, SawyerDB, ColucciWS, WalshK. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension, 47:887–893. 2006.
136.
JagerS, HandschinC, St-PierreJ, SpiegelmanBM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A, 104:12017–12022. 2007.
137.
JangYC, PerezVI, SongW, LustgartenMS, SalmonAB, MeleJ, QiW, LiuY, LiangH, ChaudhuriA, IkenoY, EpsteinCJ, Van RemmenH, RichardsonA. Overexpression of Mn superoxide dismutase does not increase life span in mice. J Gerontol A Biol Sci Med Sci, 64:1114–1125. 2009.
138.
JebaraVA, DervanianP, AcarC, GrareP, MihaileanuS, ChauvaudS, FabianiJN, DelocheA, CarpentierA. Mitral valve repair using Carpentier techniques in patients more than 70 years old. Early and late results. Circulation, 86:II53–II59. 1992.
139.
JeonDS, AtarS, BraschAV, LuoH, MirochaJ, NaqviTZ, KrausR, BermanDS, SiegelRJ. Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age<or=65 years old. J Am Coll Cardiol, 38:1988–1993. 2001.
140.
JianB, NarulaN, LiQY, MohlerER3rd, LevyRJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg, 75:457–465discussion 465–62003.
141.
JiangJC, WawrynJ, Shantha KumaraHM, JazwinskiSM. Distinct roles of processes modulated by histone deacetylases Rpd3p, Hda1p, and Sir2p in life extension by caloric restriction in yeast. Exp Gerontol, 37:1023–1030. 2002.
142.
JuhaszovaM, RabuelC, ZorovDB, LakattaEG, SollottSJ. Protection in the aged heart: preventing the heart-break of old age?Cardiovasc Res, 66:233–244. 2005.
143.
KaeberleinM, KirklandKT, FieldsS, KennedyBK. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol, 2:E296. 2004.
KaravidasA, LazarosG, TsiachrisD, PyrgakisV. Aging and the cardiovascular system. Hellenic J Cardiol, 51:421–427. 2010.
146.
KastmanEK, WilletteAA, CoeCL, BendlinBB, KosmatkaKJ, McLarenDG, XuG, CanuE, FieldAS, AlexanderAL, VoytkoML, BeasleyTM, ColmanRJ, WeindruchRH, JohnsonSC. A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys. J Neurosci, 30:7940–7947. 2010.
147.
KatzmarzykPT, LeonAS, WilmoreJH, SkinnerJS, RaoDC, RankinenT, BouchardC. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc, 35:1703–1709. 2003.
148.
KellyG. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1. Altern Med Rev, 15:245–263. 2010.
149.
KellyGS. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Altern Med Rev, 15:313–328. 2010.
150.
KelsoGF, PorteousCM, CoulterCV, HughesG, PorteousWK, LedgerwoodEC, SmithRA, MurphyMP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem, 276:4588–4596. 2001.
151.
KennedyBK, SteffenKK, KaeberleinM. Ruminations on dietary restriction and aging. Cell Mol Life Sci, 64:1323–1328. 2007.
152.
KenyonC, ChangJ, GenschE, RudnerA, TabtiangR. A C. elegans mutant that lives twice as long as wild type. Nature, 366:461–464. 1993.
153.
KimuraS, ZhangGX, NishiyamaA, ShokojiT, YaoL, FanYY, RahmanM, AbeY. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension, 45:438–444. 2005.
154.
KochLG, KemiOJ, QiN, LengSX, BijmaP, GilliganLJ, WilkinsonJE, WisloffH, HoydalMA, RolimN, AbadirPM, van GrevenhofEM, SmithGL, BurantCF, EllingsenO, BrittonSL, WisloffU. Intrinsic aerobic capacity sets a divide for aging and longevity. Circ Res, 109:1162–1172. 2011.
155.
KodamaS, TanakaS, SaitoK, ShuM, SoneY, OnitakeF, SuzukiE, ShimanoH, YamamotoS, KondoK, OhashiY, YamadaN, SoneH. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med, 167:999–1008. 2007.
156.
KohGY, SoonpaaMH, KlugMG, PrideHP, CooperBJ, ZipesDP, FieldLJ. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest, 96:2034–2042. 1995.
KorzickDH, HolimanDA, BoluytMO, LaughlinMH, LakattaEG. Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol, 281:H581–H589. 2001.
159.
KostinS, PoolL, ElsasserA, HeinS, DrexlerHC, ArnonE, HayakawaY, ZimmermannR, BauerE, KlovekornWP, SchaperJ. Myocytes die by multiple mechanisms in failing human hearts. Circ Res, 92:715–724. 2003.
160.
KosugiR, ShioiT, Watanabe-MaedaK, YoshidaY, TakahashiK, MachidaY, IzumiT. Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart. Circ J, 70:482–488. 2006.
161.
KowaldA, KirkwoodTB. Evolution of the mitochondrial fusion-fission cycle and its role in aging. Proc Natl Acad Sci U S A, 108:10237–42. 2011.
162.
KrausWE, HoumardJA, DuschaBD, KnetzgerKJ, WhartonMB, McCartneyJS, BalesCW, HenesS, SamsaGP, OtvosJD, KulkarniKR, SlentzCA. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med, 347:1483–1492. 2002.
KroemerG, LevineB. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol, 9:1004–1010. 2008.
166.
KujothGC, HionaA, PughTD, SomeyaS, PanzerK, WohlgemuthSE, HoferT, SeoAY, SullivanR, JoblingWA, MorrowJD, Van RemmenH, SedivyJM, YamasobaT, TanokuraM, WeindruchR, LeeuwenburghC, ProllaTA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309:481–484. 2005.
167.
KumaranS, SavithaS, Anusuya DeviM, PanneerselvamC. L-carnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. Mech Ageing Dev, 125:507–512. 2004.
168.
KurodaJ, AgoT, MatsushimaS, ZhaiP, SchneiderMD, SadoshimaJ. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A, 107:15565–15570. 2010.
169.
KurosuH, YamamotoM, ClarkJD, PastorJV, NandiA, GurnaniP, McGuinnessOP, ChikudaH, YamaguchiM, KawaguchiH, ShimomuraI, TakayamaY, HerzJ, KahnCR, RosenblattKP, Kuro-oM. Suppression of aging in mice by the hormone Klotho. Science, 309:1829–1833. 2005.
170.
KusamaS, UedaR, SudaT, NishiharaS, MatsuuraET. Involvement of Drosophila Sir2-like genes in the regulation of life span. Genes Genet Syst, 81:341–348. 2006.
171.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, ElliottP, GenyB, LaaksoM, PuigserverP, AuwerxJ. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127:1109–1122. 2006.
172.
LakattaEG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation, 107:490–497. 2003.
173.
LakattaEG, LevyD. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation, 107:139–146. 2003.
174.
LakattaEG, LevyD. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation, 107:346–354. 2003.
175.
LaneMA, IngramDK, RothGS. Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol Sci, 52:41–48. 1999.
176.
LaneMA, MattisonJ, IngramDK, RothGS. Caloric restriction and aging in primates: relevance to humans and possible CR mimetics. Microsc Res Tech, 59:335–338. 2002.
177.
LanzaIR, ShortDK, ShortKR, RaghavakaimalS, BasuR, JoynerMJ, McConnellJP, NairKS. Endurance exercise as a countermeasure for aging. Diabetes, 57:2933–2942. 2008.
178.
LeeRT. Matrix metalloproteinase inhibition and the prevention of heart failure. Trends Cardiovasc Med, 11:202–205. 2001.
179.
LeeSJ, HwangAB, KenyonC. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr Biol, 20:2131–2136. 2010.
180.
LennoxSD, MulkerrinE, PenneyM, WoodhouseK. Plasma atrial natriuretic polypeptide in the elderly: age or hypertension?Arch Gerontol Geriatr, 19:1–5. 1994.
181.
LeonAS, RiceT, MandelS, DespresJP, BergeronJ, GagnonJ, RaoDC, SkinnerJS, WilmoreJH, BouchardC. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study. Metabolism, 49:513–520. 2000.
182.
LeoscoD, RengoG, IaccarinoG, FilippelliA, LymperopoulosA, ZincarelliC, FortunatoF, GolinoL, MarcheseM, EspositoG, RapacciuoloA, RinaldiB, FerraraN, KochWJ, RengoF. Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. Am J Physiol Heart Circ Physiol, 293:H1596–H1603. 2007.
183.
LevineB, YuanJ. Autophagy in cell death: an innocent convict?J Clin Invest, 115:2679–2688. 2005.
184.
LiHF, ChenSA, WuSN. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+current in vascular endothelial cells. Cardiovasc Res, 45:1035–1045. 2000.
185.
LiHH, KedarV, ZhangC, McDonoughH, AryaR, WangDZ, PattersonC. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest, 114:1058–1071. 2004.
186.
LiHH, WillisMS, LockyerP, MillerN, McDonoughH, GlassDJ, PattersonC. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest, 117:3211–3223. 2007.
187.
LiL, PanR, LiR, NiemannB, AurichAC, ChenY, RohrbachS. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes, 60:157–167. 2011.
188.
LiQ, Ceylan-IsikAF, LiJ, RenJ. Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res, 11:725–733. 2008.
LinK, DormanJB, RodanA, KenyonC. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science, 278:1319–1322. 1997.
LindseyML, GannonJ, AikawaM, SchoenFJ, RabkinE, Lopresti-MorrowL, CrawfordJ, BlackS, LibbyP, MitchellPG, LeeRT. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation, 105:753–758. 2002.
196.
LindseyML, GoshornDK, SquiresCE, EscobarGP, HendrickJW, MingoiaJT, SweterlitschSE, SpinaleFG. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res, 66:410–419. 2005.
197.
LuongN, DaviesCR, WessellsRJ, GrahamSM, KingMT, VeechR, BodmerR, OldhamSM. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab, 4:133–142. 2006.
198.
MagwereT, WestM, RiyahiK, MurphyMP, SmithRA, PartridgeL. The effects of exogenous antioxidants on lifespan and oxidative stress resistance in Drosophila melanogaster. Mech Ageing Dev, 127:356–370. 2006.
199.
MammucariC, RizzutoR. Signaling pathways in mitochondrial dysfunction and aging. Mech Ageing Dev, 131:536–543. 2010.
200.
Marin-GarciaJ, GoldenthalMJ, MoeGW. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res, 52:103–110. 2001.
MattsonMP, WanR. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem, 16:129–137. 2005.
McMullenJR, SherwoodMC, TarnavskiO, ZhangL, DorfmanAL, ShioiT, IzumoS. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation, 109:3050–3055. 2004.
205.
McMullenJR, ShioiT, ZhangL, TarnavskiO, SherwoodMC, DorfmanAL, LongnusS, PendeM, MartinKA, BlenisJ, ThomasG, IzumoS. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol Cell Biol, 24:6231–6240. 2004.
206.
MeyerTE, KovacsSJ, EhsaniAA, KleinS, HolloszyJO, FontanaL. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol, 47:398–402. 2006.
207.
MillerRA, HarrisonDE, AstleCM, BaurJA, BoydAR, de CaboR, FernandezE, FlurkeyK, JavorsMA, NelsonJF, OrihuelaCJ, PletcherS, SharpZD, SinclairD, StarnesJW, WilkinsonJE, NadonNL, StrongR. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci, 66:191–201. 2011.
208.
MinamisawaS, HoshijimaM, ChuG, WardCA, FrankK, GuY, MartoneME, WangY, RossJJr., KraniasEG, GilesWR, ChienKR. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell, 99:313–322. 1999.
209.
MinamiyamaY, BitoY, TakemuraS, TakahashiY, KodaiS, MizuguchiS, NishikawaY, SuehiroS, OkadaS. Calorie restriction improves cardiovascular risk factors via reduction of mitochondrial reactive oxygen species in type II diabetic rats. J Pharmacol Exp Ther, 320:535–543. 2007.
210.
MiyamotoMI, del MonteF, SchmidtU, DiSalvoTS, KangZB, MatsuiT, GuerreroJL, GwathmeyJK, RosenzweigA, HajjarRJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A, 97:793–798. 2000.
211.
MizutaniK, IkedaK, KawaiY, YamoriY. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol, 28:55–59. 2001.
212.
MockettRJ, BayneAC, KwongLK, OrrWC, SohalRS. Ectopic expression of catalase in Drosophila mitochondria increases stress resistance but not longevity. Free Radic Biol Med, 34:207–217. 2003.
213.
MockettRJ, SohalRS, OrrWC. Overexpression of glutathione reductase extends survival in transgenic Drosophila melanogaster under hyperoxia but not normoxia. FASEB J, 13:1733–1742. 1999.
214.
MollnauH, WendtM, SzocsK, LassegueB, SchulzE, OelzeM, LiH, BodenschatzM, AugustM, KleschyovAL, TsilimingasN, WalterU, ForstermannU, MeinertzT, GriendlingK, MunzelT. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res, 90:E58–E65. 2002.
215.
MoraS, LeeIM, BuringJE, RidkerPM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA, 295:1412–1419. 2006.
216.
MurphyMP, SmithRA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol, 47:629–656. 2007.
217.
MurrayAJ, AndersonRE, WatsonGC, RaddaGK, ClarkeK. Uncoupling proteins in human heart. Lancet, 364:1786–1788. 2004.
218.
MuscariC, CaldareraCM, GuarnieriC. Age-dependent production of mitochondrial hydrogen peroxide, lipid peroxides and fluorescent pigments in the rat heart. Basic Res Cardiol, 85:172–178. 1990.
219.
MusterAJ, KimH, KaneB, McPhersonDD. Ten-year echo/doppler determination of the benefits of aerobic exercise after the age of 65 years. Echocardiography, 27:5–10. 2010.
220.
MuthusamyVR, KannanS, SadhaasivamK, GounderSS, DavidsonCJ, BoehemeC, HoidalJR, WangL, SoorappanRN. Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic Biol Med, 52:366–376. 2012.
221.
Nadal-GinardB, KajsturaJ, LeriA, AnversaP. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res, 92:139–150. 2003.
222.
NakadaK, InoueK, OnoT, IsobeK, OguraA, GotoYI, NonakaI, HayashiJI. Inter-mitochondrial complementation: mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med, 7:934–940. 2001.
223.
NakadaK, SatoA, HayashiJ. Mitochondrial functional complementation in mitochondrial DNA-based diseases. Int J Biochem Cell Biol, 41:1907–1913. 2009.
224.
NakaeI, MitsunamiK, OmuraT, YabeT, TsutamotoT, MatsuoS, TakahashiM, MorikawaS, InubushiT, NakamuraY, KinoshitaM, HorieM. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol, 42:1587–1593. 2003.
225.
NakaiA, YamaguchiO, TakedaT, HiguchiY, HikosoS, TaniikeM, OmiyaS, MizoteI, MatsumuraY, AsahiM, NishidaK, HoriM, MizushimaN, OtsuK. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med, 13:619–624. 2007.
226.
NakayamaH, ChenX, BainesCP, KlevitskyR, ZhangX, ZhangH, JaleelN, ChuaBH, HewettTE, RobbinsJ, HouserSR, MolkentinJD. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest, 117:2431–2444. 2007.
227.
NassimihaD, AronowWS, AhnC, GoldmanME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol, 87:1313–1314. 2001.
228.
NavarroA, BoverisA. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol, 292:C670–C686. 2007.
229.
NeubauerS, HornM, CramerM, HarreK, NewellJB, PetersW, PabstT, ErtlG, HahnD, IngwallJS, KochsiekK. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation, 96:2190–2196. 1997.
230.
NiemannB, ChenY, IssaH, SilberRE, RohrbachS. Caloric restriction delays cardiac ageing in rats: role of mitochondria. Cardiovasc Res, 88:267–276. 2010.
231.
NiemannB, ChenY, TeschnerM, LiL, SilberRE, RohrbachS. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol, 57:577–585. 2011.
232.
NittaY, AbeK, AokiM, OhnoI, IsoyamaS. Diminished heat shock protein 70 mRNA induction in aged rat hearts after ischemia. Am J Physiol, 267:H1795–H1803. 1994.
233.
O'MalleyY, FinkBD, RossNC, PrisinzanoTE, SivitzWI. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem, 281:39766–39775. 2006.
O'RourkeMF, HashimotoJ. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol, 50:1–13. 2007.
236.
OcorrK, AkasakaT, BodmerR. Age-related cardiac disease model of Drosophila. Mech Ageing Dev, 128:112–116. 2007.
237.
OcorrK, ReevesNL, WessellsRJ, FinkM, ChenHS, AkasakaT, YasudaS, MetzgerJM, GilesW, PosakonyJW, BodmerR. KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. Proc Natl Acad Sci U S A, 104:3943–3948. 2007.
238.
OhH, TaffetGE, YoukerKA, EntmanML, OverbeekPA, MichaelLH, SchneiderMD. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A, 98:10308–10313. 2001.
239.
OkaT, KomuroI. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure. Circulation JSupp A:A13–A16. 2008.
240.
OkumuraS, TakagiG, KawabeJ, YangG, LeeMC, HongC, LiuJ, VatnerDE, SadoshimaJ, VatnerSF, IshikawaY. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A, 100:9986–9990. 2003.
241.
OkumuraS, VatnerDE, KurotaniR, BaiY, GaoS, YuanZ, IwatsuboK, UlucanC, KawabeJ, GhoshK, VatnerSF, IshikawaY. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation, 116:1776–1783. 2007.
242.
OlsenMH, WachtellK, BellaJN, GerdtsE, PalmieriV, NieminenMS, SmithG, IbsenH, DevereuxRB. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)Am J Cardiol, 95:132–136. 2005.
243.
OralloF, AlvarezE, CaminaM, LeiroJM, GomezE, FernandezP. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol, 61:294–302. 2002.
244.
OshiroN, YoshinoK, HidayatS, TokunagaC, HaraK, EguchiS, AvruchJ, YonezawaK. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells, 9:359–366. 2004.
245.
OttoCM. Why is aortic sclerosis associated with adverse clinical outcomes?J Am Coll Cardiol, 43:176–178. 2004.
246.
OttoCM, LindBK, KitzmanDW, GershBJ, SiscovickDS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med, 341:142–147. 1999.
247.
PaddenbergR, StiegerP, von LilienAL, FaulhammerP, GoldenbergA, TillmannsHH, KummerW, Braun-DullaeusRC. Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Respir Res, 8:15. 2007.
248.
PalaciosOM, CarmonaJJ, MichanS, ChenKY, ManabeY, WardJL3rd, GoodyearLJ, TongQ. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY), 1:771–783. 2009.
249.
PanagiotakosDB, PitsavosC, ChrysohoouC, SkoumasJ, TousoulisD, ToutouzaM, ToutouzasP, StefanadisC. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J, 147:106–112. 2004.
250.
ParkesTL, EliaAJ, DickinsonD, HillikerAJ, PhillipsJP, BoulianneGL. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat Genet, 19:171–174. 1998.
251.
PatelKR, BrownVA, JonesDJ, BrittonRG, HemingwayD, MillerAS, WestKP, BoothTD, PerloffM, CrowellJA, BrennerDE, StewardWP, GescherAJ, BrownK. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res, 70:7392–7399. 2010.
252.
PatelKR, ScottE, BrownVA, GescherAJ, StewardWP, BrownK. Clinical trials of resveratrol. Ann N Y Acad Sci, 1215:161–169. 2011.
253.
PerezVI, Van RemmenH, BokovA, EpsteinCJ, VijgJ, RichardsonA. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell, 8:73–75. 2009.
254.
PetriS, KiaeiM, DamianoM, HillerA, WilleE, ManfrediG, CalingasanNY, SzetoHH, BealMF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem, 98:1141–1148. 2006.
255.
PillaiVB, SundaresanNR, KimG, GuptaM, RajamohanSB, PillaiJB, SamantS, RavindraPV, IsbatanA, GuptaMP. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem, 285:3133–3144. 2010.
256.
PiotC, CroisilleP, StaatP, ThibaultH, RioufolG, MewtonN, ElbelghitiR, CungTT, BonnefoyE, AngoulvantD, MaciaC, RaczkaF, SportouchC, GahideG, FinetG, Andre-FouetX, RevelD, KirkorianG, MonassierJP, DerumeauxG, OvizeM. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med, 359:473–481. 2008.
257.
Plecita-HlavataL, JezekJ, JezekP. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I. Int J Biochem Cell Biol, 41:1697–1707. 2009.
258.
PoderosoJJ, CarrerasMC, LisderoC, RioboN, SchopferF, BoverisA. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys, 328:85–92. 1996.
259.
PolakJF, PencinaMJ, PencinaKM, O'DonnellCJ, WolfPA, D'AgostinoRBSr.Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med, 365:213–221. 2011.
RabinowitzM, ZakR. Mitochondria and cardiac hypertrophy. Circ Res, 36:367–376. 1975.
262.
RadiR, CassinaA, HodaraR, QuijanoC, CastroL. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med, 33:1451–1464. 2002.
263.
RavikumarB, VacherC, BergerZ, DaviesJE, LuoS, OrozLG, ScaravilliF, EastonDF, DudenR, O'KaneCJ, RubinszteinDC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet, 36:585–595. 2004.
264.
RebrinI, KamzalovS, SohalRS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radic Biol Med, 35:626–635. 2003.
265.
RebrinI, SohalRS. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol, 39:1513–1519. 2004.
266.
RedfieldMM, RodehefferRJ, JacobsenSJ, MahoneyDW, BaileyKR, BurnettJCJr.Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol, 40:976–982. 2002.
267.
RemondinoA, KwonSH, CommunalC, PimentelDR, SawyerDB, SinghK, ColucciWS. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res, 92:136–138. 2003.
268.
ReznickRM, ZongH, LiJ, MorinoK, MooreIK, YuHJ, LiuZX, DongJ, MustardKJ, HawleySA, BefroyD, PypaertM, HardieDG, YoungLH, ShulmanGI. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab, 5:151–156. 2007.
269.
RiordanMM, WeissEP, MeyerTE, EhsaniAA, RacetteSB, VillarealDT, FontanaL, HolloszyJO, KovacsSJ. The effects of caloric restriction- and exercise-induced weight loss on left ventricular diastolic function. Am J Physiol Heart Circ Physiol, 294:H1174–H1182. 2008.
270.
RistowM, ZarseK. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis)Exp Gerontol, 45:410–418. 2010.
271.
RistowM, ZarseK, OberbachA, KlotingN, BirringerM, KiehntopfM, StumvollM, KahnCR, BluherM. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A, 106:8665–8670. 2009.
272.
RodrigoR, MirandaA, VergaraL. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta, 412:410–424. 2011.
273.
RogerVL, GoAS, Lloyd-JonesDM, AdamsRJ, BerryJD, BrownTM, CarnethonMR, DaiS, de SimoneG, FordES, FoxCS, FullertonHJ, GillespieC, GreenlundKJ, HailpernSM, HeitJA, Michael HoP, HowardVJ, KisselaBM, KittnerSJ, LacklandDT, LichtmanJH, LisabethLD, MakucDM, MarcusGM, MarelliA, MatcharDB, McDermottMM, MeigsJB, MoyCS, MozaffarianD, MussolinoME, NicholG, PaynterNP, RosamondWD, SorliePD, StaffordRS, TuranTN, TurnerMB, WongND, Wylie-RosettJ. Executive Summary: Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association. Circulation, 123:459–463. 2011.
274.
RohdeLE, DucharmeA, ArroyoLH, AikawaM, SukhovaGH, Lopez-AnayaA, McClureKF, MitchellPG, LibbyP, LeeRT. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation, 99:3063–3070. 1999.
275.
RohrbachS, NiemannB, AbushoukAM, HoltzJ. Caloric restriction and mitochondrial function in the ageing myocardium. Exp Gerontol, 41:525–531. 2006.
276.
RonnebaumSM, PattersonC. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol, 72:81–94. 2010.
277.
RossignolR, MalgatM, MazatJP, LetellierT. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem, 274:33426–33432. 1999.
278.
RotaM, LeCapitaineN, HosodaT, BoniA, De AngelisA, Padin-IruegasME, EspositoG, VitaleS, UrbanekK, CasarsaC, GiorgioM, LuscherTF, PelicciPG, AnversaP, LeriA, KajsturaJ. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res, 99:42–52. 2006.
279.
RothGS, MattisonJA, OttingerMA, ChachichME, LaneMA, IngramDK. Aging in rhesus monkeys: relevance to human health interventions. Science, 305:1423–1426. 2004.
280.
RudolphKL, ChangS, LeeHW, BlascoM, GottliebGJ, GreiderC, DePinhoRA. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96:701–712. 1999.
281.
SachsHG, ColganJA, LazarusML. Ultrastructure of the aging myocardium: a morphometric approach. Am J Anat, 150:63–71. 1977.
282.
SadoshimaJ, QiuZ, MorganJP, IzumoS. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res, 76:1–15. 1995.
283.
SafdarA, BourgeoisJM, OgbornDI, LittleJP, HettingaBP, AkhtarM, ThompsonJE, MelovS, MocellinNJ, KujothGC, ProllaTA, TarnopolskyMA. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci U S A, 2011.
284.
SangaralinghamSJ, HuntleyBK, MartinFL, McKiePM, BellaviaD, IchikiT, HardersGE, ChenHH, BurnettJCJr.The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide. Hypertension, 57:201–207. 2011.
285.
SauveAA, CahillSM, ZechSG, BassoLA, LewandowiczA, SantosDS, GrubmeyerC, EvansGB, FurneauxRH, TylerPC, McDermottA, GirvinME, SchrammVL. Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases. Biochemistry, 42:5694–5705. 2003.
286.
SauveAA, CelicI, AvalosJ, DengH, BoekeJD, SchrammVL. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry, 40:15456–15463. 2001.
287.
SauveAA, SchrammVL. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry, 42:9249–9256. 2003.
288.
ScatenaR, BottoniP, BottaG, MartoranaGE, GiardinaB. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol, 293:C12–C21. 2007.
289.
SchrinerSE, LinfordNJ, MartinGM, TreutingP, OgburnCE, EmondM, CoskunPE, LadigesW, WolfN, Van RemmenH, WallaceDC, RabinovitchPS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 308:1909–1911. 2005.
290.
SchulzTJ, ZarseK, VoigtA, UrbanN, BirringerM, RistowM. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab, 6:280–293. 2007.
291.
SeymourEM, ParikhRV, SingerAA, BollingSF. Moderate calorie restriction improves cardiac remodeling and diastolic dysfunction in the Dahl-SS rat. J Mol Cell Cardiol, 41:661–668. 2006.
292.
ShinmuraK. Cardiovascular protection afforded by caloric restriction: essential role of nitric oxide synthase. Geriatr Gerontol Int, 11:143–156. 2011.
293.
ShinmuraK, TamakiK, BolliR. Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. Am J Physiol Heart Circ Physiol, 295:H2348–H2355. 2008.
294.
ShinmuraK, TamakiK, SanoM, MurataM, YamakawaH, IshidaH, FukudaK. Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol, 50:117–127. 2011.
ShiojimaI, SatoK, IzumiyaY, SchiekoferS, ItoM, LiaoR, ColucciWS, WalshK. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest, 115:2108–2118. 2005.
297.
ShonoM, YoshimuraM, NakayamaM, YamamuroM, AbeK, SuzukiS, MizunoY, SugiyamaS, SaitoY, NakaoK, YasueH, OgawaH. Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure. Circ J, 71:1040–1046. 2007.
SnowBJ, RolfeFL, LockhartMM, FramptonCM, O'SullivanJD, FungV, SmithRA, MurphyMP, TaylorKM. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord, 25:1670–1674. 2010.
300.
SohalRS, SohalBH. Hydrogen peroxide release by mitochondria increases during aging. Mech Ageing Dev, 57:187–202. 1991.
301.
SpinaleFG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev, 87:1285–1342. 2007.
302.
St-PierreJ, DroriS, UldryM, SilvaggiJM, RheeJ, JagerS, HandschinC, ZhengK, LinJ, YangW, SimonDK, BachooR, SpiegelmanBM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127:397–408. 2006.
303.
StahlM, DijkersPF, KopsGJ, LensSM, CofferPJ, BurgeringBM, MedemaRH. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol, 168:5024–5031. 2002.
304.
SteinM, BoulaksilM, JansenJA, HeroldE, NoormanM, JolesJA, van VeenTA, HoutmanMJ, EngelenMA, HauerRN, de BakkerJM, van RijenHV. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol, 299:H310–H321. 2010.
305.
SteinhublSR. Why have antioxidants failed in clinical trials?Am J Cardiol, 101:14D–19D. 2008.
306.
StewartBF, SiscovickD, LindBK, GardinJM, GottdienerJS, SmithVE, KitzmanDW, OttoCM. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol, 29:630–634. 1997.
307.
SulaimanM, MattaMJ, SunderesanNR, GuptaMP, PeriasamyM, GuptaM. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol, 298:H833–H843. 2010.
308.
SundaresanNR, GuptaM, KimG, RajamohanSB, IsbatanA, GuptaMP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest, 119:2758–2771. 2009.
SzetoHH, SchillerPW, ZhaoK, LuoG. Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides. FASEB J, 19:118–120. 2005.
313.
TaffetGE, PhamTT, HartleyCJ. The age-associated alterations in late diastolic function in mice are improved by caloric restriction. J Gerontol A Biol Sci Med Sci, 52:B285–B290. 1997.
314.
Taghli-LamallemO, AkasakaT, HoggG, NudelU, YaffeD, ChamberlainJS, OcorrK, BodmerR. Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype. Aging Cell, 7:237–249. 2008.
315.
TakemotoKA, BernsteinL, LopezJF, MarshakD, RahimtoolaSH, ChandraratnaPA. Abnormalities of diastolic filling of the left ventricle associated with aging are less pronounced in exercise-trained individuals. Am Heart J, 124:143–148. 1992.
316.
TaniM, HonmaY, HasegawaH, TamakiK. Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res, 49:56–68. 2001.
317.
TatarM, KopelmanA, EpsteinD, TuMP, YinCM, GarofaloRS. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science, 292:107–110. 2001.
318.
TermanA, BrunkUT. The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ, 14:107–114. 2005.
319.
TermanA, GustafssonB, BrunkUT. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact, 163:29–37. 2006.
TermanA, KurzT, GustafssonB, BrunkUT. The involvement of lysosomes in myocardial aging and disease. Curr Cardiol Rev, 4:107–115. 2008.
322.
TermanA, KurzT, NavratilM, ArriagaEA, BrunkUT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal, 12:503–535. 2010.
323.
TerziogluM, LarssonNG. Mitochondrial dysfunction in mammalian ageing. Novartis Found Symp, 287:197–208discussion 208–2132007.
324.
TrifunovicA, LarssonNG. Mitochondrial dysfunction as a cause of ageing. J Intern Med, 263:167–178. 2008.
TwigG, ElorzaA, MolinaAJ, MohamedH, WikstromJD, WalzerG, StilesL, HaighSE, KatzS, LasG, AlroyJ, WuM, PyBF, YuanJ, DeeneyJT, CorkeyBE, ShirihaiOS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J, 27:433–446. 2008.
327.
UmpierreD, RibeiroPA, KramerCK, LeitaoCB, ZucattiAT, AzevedoMJ, GrossJL, RibeiroJP, SchaanBD. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA, 305:1790–1799. 2011.
328.
van EmpelVP, BertrandAT, van OortRJ, van der NagelR, EngelenM, van RijenHV, DoevendansPA, CrijnsHJ, AckermanSL, SluiterW, De WindtLJ. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol, 48:824–832. 2006.
329.
Van RaamsdonkJM, HekimiS. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet, 5:e1000361. 2009.
330.
VaradyKA, HellersteinMK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr, 86:7–13. 2007.
331.
VasanRS, DemissieS, KimuraM, CupplesLA, RifaiN, WhiteC, WangTJ, GardnerJP, CaoX, BenjaminEJ, LevyD, AvivA. Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System. The Framingham Heart Study. Circulation, 117:1138–1144. 2008.
332.
VasanRS, SullivanLM, D'AgostinoRB, RoubenoffR, HarrisT, SawyerDB, LevyD, WilsonPW. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med, 139:642–648. 2003.
333.
Ventura-ClapierR, GarnierA, VekslerV. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res, 79:208–217. 2008.
334.
VergeadeA, MulderP, Vendeville-DehaudtC, EstourF, FortinD, Ventura-ClapierR, ThuillezC, MonteilC. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ. Free Radic Biol Med, 49:748–756. 2010.
335.
VermulstM, WanagatJ, KujothGC, BielasJH, RabinovitchPS, ProllaTA, LoebLA. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet, 40:392–394. 2008.
336.
VivekananthanDP, PennMS, SappSK, HsuA, TopolEJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 361:2017–2023. 2003.
337.
WaddenTA, BerkowitzRI, WombleLG, SarwerDB, PhelanS, CatoRK, HessonLA, OseiSY, KaplanR, StunkardAJ. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med, 353:2111–2120. 2005.
338.
WanagatJ, CaoZ, PathareP, AikenJM. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J, 15:322–332. 2001.
339.
WangZ, HuangY, ZouJ, CaoK, XuY, WuJM. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med, 9:77–79. 2002.
340.
WangZ, ZouJ, CaoK, HsiehTC, HuangY, WuJM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med, 16:533–540. 2005.
341.
WeissRG, GerstenblithG, BottomleyPA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A, 102:808–813. 2005.
342.
WenCP, WaiJP, TsaiMK, YangYC, ChengTY, LeeMC, ChanHT, TsaoCK, TsaiSP, WuX. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet, 378:1244–1253. 2011.
343.
WenckerD, ChandraM, NguyenK, MiaoW, GarantziotisS, FactorSM, ShiraniJ, ArmstrongRC, KitsisRN. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest, 111:1497–1504. 2003.
344.
WessellsR, HayesM, BodmerR. Cardiac functional decline with age is dependent upon regulation of 4EBP activity in the myocardium. A Dros Res Conf, 48:882C. 2007.
345.
WessellsRJ, FitzgeraldE, CypserJR, TatarM, BodmerR. Insulin regulation of heart function in aging fruit flies. Nat Genet, 36:1275–1281. 2004.
346.
WhitemanM, SpencerJP, SzetoHH, ArmstrongJS. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?Antioxid Redox Signal, 10:641–650. 2008.
347.
WohlgemuthSE, JulianD, AkinDE, FriedJ, ToscanoK, LeeuwenburghC, DunnWAJr.Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res, 10:281–292. 2007.
348.
WolfMJ, AmreinH, IzattJA, ChomaMA, ReedyMC, RockmanHA. Drosophila as a model for the identification of genes causing adult human heart disease. Proc Natl Acad Sci U S A, 103:1394–1399. 2006.
349.
WoodJG, RoginaB, LavuS, HowitzK, HelfandSL, TatarM, SinclairD. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430:686–689. 2004.
350.
WuD, SoongY, ZhaoGM, SzetoHH. A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning. Am J Physiol Heart Circ Physiol, 283:H783–H791. 2002.
351.
YanL, VatnerDE, O'ConnorJP, IvessaA, GeH, ChenW, HirotaniS, IshikawaY, SadoshimaJ, VatnerSF. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell, 130:247–258. 2007.
352.
YounesA, BoluytMO, O'NeillL, MeredithAL, CrowMT, LakattaEG. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol, 269:H1003–H1008. 1995.
353.
ZhangC, BillsM, QuigleyA, MaxwellRJ, LinnaneAW, NagleyP. Varied prevalence of age-associated mitochondrial DNA deletions in different species and tissues: a comparison between human and rat. Biochem Biophys Res Commun, 230:630–635. 1997.
354.
ZhangY, IkenoY, QiW, ChaudhuriA, LiY, BokovA, ThorpeSR, BaynesJW, EpsteinC, RichardsonA, Van RemmenH. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci, 1–9. 2009.
355.
ZhaoK, LuoG, GiannelliS, SzetoHH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol, 70:1796–1806. 2005.
